uniQure (QURE) Change in Accured Expenses (2016 - 2026)
uniQure (QURE) recorded quarterly Change in Accured Expenses of $3.9 million in Q1 2026, up 126.25% quarter-over-quarter from -$14.8 million in Q4 2025, and up 423.49% on a YoY basis from $744624.3 in Q1 2025.
uniQure (QURE) Change in Accured Expenses (2016 - 2026) Analysis & Trends
uniQure's Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 423.49% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $9.6 million (up 656.48% YoY), while the FY2025 annual figure was $4.5 million, up 179.3% from the prior year.
- Change in Accured Expenses was $3.9 million for Q1 2026 at uniQure, up from -$14.8 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $22.6 million in Q3 2025 to a low of -$14.8 million in Q4 2025.
- Historically, Change in Accured Expenses has averaged $46294.1 across 5 years, with a median of -$248000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses tumbled 682.77% in 2024, then surged 537.32% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at -$248000.0 in 2022, then jumped by 373.79% to $679000.0 in 2023, then sank by 682.77% to -$4.0 million in 2024, then slumped by 275.21% to -$14.8 million in 2025, then jumped by 126.25% to $3.9 million in 2026.
- The last three Change in Accured Expenses figures came in at $3.9 million (Q1 2026), -$14.8 million (Q4 2025), and $22.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.90 Mn |
| Mar 31, 2026 | 3.90 Mn |
| Dec 31, 2025 | -14.85 Mn |
| Dec 31, 2025 | -14.85 Mn |
| Sep 30, 2025 | 22.59 Mn |
| Sep 30, 2025 | 22.59 Mn |
| Jun 30, 2025 | -2.07 Mn |
| Jun 30, 2025 | -2.07 Mn |
| Mar 31, 2025 | -1.21 Mn |
| Mar 31, 2025 | -1.21 Mn |
| Dec 31, 2024 | -3.96 Mn |
| Dec 31, 2024 | -3.96 Mn |
| Sep 30, 2024 | 3.55 Mn |
| Sep 30, 2024 | 3.55 Mn |
| Jun 30, 2024 | 2.88 Mn |
| Jun 30, 2024 | 2.88 Mn |
| Mar 31, 2024 | -8.11 Mn |
| Mar 31, 2024 | -8.11 Mn |
| Dec 31, 2023 | 679,000.00 |
| Dec 31, 2023 | 679,000.00 |